LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Strona główna・Stock List・Abbott Laboratories

Abbott Laboratories

Closed

Sector Healthcare

113.86 0.79

Buy Sell

Overview

Share price change

24h

Current

Min

113.55

Max

114.24

Key metrics
By Trading Economics
Income	77M 1.3B
Sales	420M 10B
P/E Sector Avg	32.37 103.001
EPS	1.14
Profit margin	12.543
Employees	114,000
EBITDA	170M 2.6B

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+12.36 upside

Dividends
By Dow Jones
Next Earnings	16 paź 2024
Next Dividend date	13 lis 2024
Next Ex Dividend date	10 paź 2024

Market Stats
By TradingEconomics
Market Cap	197B
Previous open	113.07
Previous close	113.86

News Sentiment

By Acuity

52%

48%

278 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

113.255 / 114.66 Support & Resistance

Abbott Laboratories Chart

Related News

29 lip 2024, 10:30 UTC

Major Market Movers

Abbott Laboratories Shares Tumble on $495 Million Infant Formula Verdict

29 lip 2024, 09:27 UTC

Major Market Movers

Reckitt Benckiser Shares Tumble on Abbott's Baby-Formula Litigation

18 lip 2024, 12:21 UTC

Earnings

Abbott Labs Lifts FY24 Outlook After 2Q Sales Rise

29 lip 2024, 10:15 UTC

Major Market Movers

Abbott Laboratories Shares Tumble on $495 Mln Infant Formula Verdict

29 lip 2024, 08:50 UTC

Hot Stocks

Stocks to Watch Monday: Coinbase, Abbott, McDonald's, Heineken -- WSJ

18 lip 2024, 19:04 UTC

Market Talk

Earnings

Abbott CEO Warns of Health Crisis if Preterm Formula Pulled -- Market Talk

18 lip 2024, 11:43 UTC

Earnings

Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised -- IBD

18 lip 2024, 11:34 UTC

Earnings

Abbott Labs Sees 3Q Adj EPS $1.18-Adj EPS $1.22 >ABT

18 lip 2024, 11:34 UTC

Earnings

Abbott Labs Sees 3Q EPS 85c-EPS 89c >ABT

18 lip 2024, 11:31 UTC

Earnings

Abbott Labs Narrows FY24 Organic Sales Growth View, Ex-COVID-19 Testing-Related Sales, to 9.5% to 10% >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs Sees FY Adj EPS $4.61-Adj EPS $4.71 >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs Sees FY EPS $3.30-EPS $3.40 >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs 2Q Organic Sales Growth Up 7.4% >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs 2Q Sales $10.38B >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs 2Q Adj EPS $1.14 >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs 2Q Net $1.3B >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Labs 2Q EPS 74c >ABT

18 lip 2024, 11:30 UTC

Earnings

Abbott Raises Full-Yr Guidance

14 lip 2024, 22:41 UTC

Earnings

Stocks Poised for Higher Open -- Barrons.com

12 lip 2024, 23:29 UTC

Acquisitions, Mergers, Takeovers

BP Says Oil Demand Is Falling, While OPEC Says It's Rising. What Gives? -- Barrons.com

17 kwi 2024, 13:54 UTC

Earnings

Abbott Labs Stock Is Slipping After Earnings Beat. Here's Why. -- Barrons.com

17 kwi 2024, 12:41 UTC

Peer Comparison

Price change

Abbott Laboratories Forecast

Price Target

By TipRanks

12.36% upside

12 Months Forecast

Average 127.08 USD 12.36%

High 143 USD

Low 107 USD

Based on 14 Wall Street analysts offering 12 month price targets forAbbott Laboratories - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

14 ratings

Buy

Hold

Sell

Based on 14 analysts giving stock ratings to Abbott Laboratories - Dist in the past 3 months.

Technical Score

By Trading Central

113.255 / 114.66Support & Resistance

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

278 / 365 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.